Global Factor Views - January 2022


Macroeconomic and equity market backdrop

Growth

We expect fading virus concerns to allow the post-covid economic rebound to persist despite continued supply pressures and less favourable monetary conditions compared to 2021. We expect global GDP to grow by 4.2% in 2022 and by 3.6% in 2023.

Inflation and Rates

Near term rising headline inflation, ongoing ‘inflation anxiety’ due to supply chain disruption and a more hawkish Fed is likely to put further upward pressure on both nominal and real US bond yields. While inflationary pressures could ease in the second half of 2022, we expect most Central Banks to tighten their monetary stance during 2022.

Elevated risks

We face increased growth and policy risks. Central banks face a challenging balancing act of managing inflation while avoiding acting too fast and stifling growth. Risks are compounded because current supply chain disruptions are without precedent and Covid has not gone away.

Equity markets

Overall we maintain a cautiously positive stance on equities as economic growth remains supportive of corporate revenue growth and valuations remain attractive compared to bonds. However, we do not expect a repeat of the double digit returns of last year in 2022. We believe a cautiously positive stance is appropriate to reflect elevated economic and policy risks and because rising costs may translate to margin pressure which suppresses earnings growth.

Given this back drop we update our outlook for equity market factors below.

Quality 

Positive 

Against a backdrop of rising macro risks and ongoing supply chain disruptions which may lead to margin pressures, investors are likely to favour companies with a strong track record of earnings delivery. As such we maintain our overweight stance on quality. We do note that some areas of quality remain expensive and would advocate for an active approach to avoid expensive quality stocks

Low Volatility

Neutral

Rising inflation and higher bond yields typically weigh on the performance of the low volatility factor particularly via the factor’s exposure to bond proxies. However, we maintain a neutral stance because the interest rate environment in the months ahead carries with it elevated growth and policy risks which increases the prospect of bouts of risk-off behaviour, which typically favours lower volatility stocks.

Value 

Positive

Value remains cheaper than normal. The prospect of higher real and nominal bond yields should be supportive of value styles and may put pressure on the most expensive growth names. We upgrade our outlook on value to positive but do advocate a focus on ‘quality-value’ names due to elevated growth and policy risks in the months ahead.

Momentum 

Negative

We remain cautious of trailing measures of share price movement as a predictor of future returns, especially when the elevated growth and policy risks may result in bouts of risk on and risk off behaviour. Within the spectrum of momentum signals, near-term earnings revisions are likely to be a better gauge of market sentiment.

Source: AXA IM, January 2022. The views expressed above are as of the date of this document. No guarantee or warranty is made regarding the outlook above. Investors should not base their investment decisions on the commentary provided and should consult their advisers before doing so.


Global factor performance: Last three months

Rising bonds yields and shifting sentiment regarding the pace of fiscal tightening has driven significant factor performance dispersion in early 2022. Value delivered strong performance during January, a rally that has been consistent with the rise in US 10-year bond yields.

Global factor performance in 2021

Value and earnings revisions performed well during 2021. Quality (ROE) provided solid returns in strong up-markets especially during H2 2021. 

Source for both charts: AXA IM. Factor returns data presented as of January 18th, 2021. The chart plots univariate factor returns calculated by AXA IM Equities based on MSCI World investment universe. The data are shown for illustrative purposes only and are not based on actual portfolio returns. Past performance is not a guide to future performance. 

Read the full article
Download article (459.55 KB)

Related Articles

Equities

Robotech Stories: Identify opportunities with surgical precision

Equities

Global Factor Views: Macroeconomics favour Quality and Low Volatility stocks

Equities

Ready to emerge into new markets? Harness developing potential with climate-friendly ETFs

    Disclaimer

    This document is for informational purposes only and does not constitute investment research or financial analysis relating to transactions in financial instruments as per MIF Directive (2014/65/EU), nor does it constitute on the part of AXA Investment Managers or its affiliated companies an offer to buy or sell any investments, products or services, and should not be considered as solicitation or investment, legal or tax advice, a recommendation for an investment strategy or a personalized recommendation to buy or sell securities.
    Due to its simplification, this document is partial and opinions, estimates and forecasts herein are subjective and subject to change without notice. There is no guarantee forecasts made will come to pass. Data, figures, declarations, analysis, predictions and other information in this document is provided based on our state of knowledge at the time of creation of this document. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. Reliance upon information in this material is at the sole discretion of the recipient. This material does not contain sufficient information to support an investment decision.
    Issued in the UK by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the UK. Registered in England and Wales No: 01431068. Registered Office: 22 Bishopsgate London EC2N 4BQ
    In other jurisdictions, this document is issued by AXA Investment Managers SA’s affiliates in those countries.
    The Global Industry Classification Standard (“GICS”) is the exclusive property and a service mark of MSCI Inc. (“MSCI”) and Standard & Poor’s, a division of The McGraw-Hill Companies, Inc. (“S&P”) and is licensed for use by [Licensee]. Neither MSCI, S&P nor any third party involved in making or compiling the GICS makes any express or implied warranties or representations and shall have no liability whatsoever with respect to GICS or the results to be obtained by the use thereof.
    Neither MSCI nor any other party involved in or related to compiling, computing or creating the MSCI data makes any express or implied warranties or representations with respect to such data (or the results to be obtained by the use thereof), and all such parties hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of such data. Without limiting any of the foregoing, in no event shall MSCI, any of its affiliates or any third party involved in or related to compiling, computing or creating the data have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) even if notified of the possibility of such damages. No further distribution or dissemination of the MSCI data is permitted without MSCI’s express written consent.
    ©2021 AXA Investment Managers. All rights reserved.